Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia
Clinical trial NCT06826430 · RECRUITING
Trial details
- NCT number
- NCT06826430
- Sponsor
- Juventas Cell Therapy Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-01
- Primary completion
- 2026-03-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.